Evaluation of Clinical Outcomes Associated With Phenobarbital With Taper Compared to No Taper for the Management of Alcohol Withdrawal Syndrome

被引:0
|
作者
Thaller, Matthew [1 ]
Wong, Adrian [1 ]
Yankama, Tuyen [1 ]
Eche, Ifeoma Mary [1 ]
Elsamadisi, Pansy [1 ]
机构
[1] Beth Israel Deaconess Med Ctr, Dept Pharm, One Deaconess Rd, Boston, MA 02215 USA
关键词
barbiturates; drug; alcohol; and substance use; withdrawal; sedatives; critical care; drug interactions; SCALE;
D O I
10.1177/10600280241236412
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Phenobarbital (PHB) has been shown to be an effective treatment of alcohol withdrawal syndrome (AWS), with multiple dosing strategies used (e.g., single-dose and symptom-triggered). Studies have often used tapered doses, typically following a front-loaded dose, despite PHB's long half-life which should lead to an ability to auto-taper.Objective: The purpose of this study was to compare clinical outcomes associated with two PHB dosing strategies (taper [T], no taper [NT]) for AWS.Methods: This retrospective cohort study compared adult patients admitted to the ICU from October 2017 to May 2019 who received an initial loading dose of PHB for AWS. The use of PHB was at the discretion of the clinician per our institutional guidelines. Prior to November 2018, patients were prescribed a PHB taper, while after this period, the taper was no longer recommended. The primary outcome was the proportion of patients requiring rescue PHB or adjunctive medications for AWS. Secondary outcomes included number of adjunctive agents used, prevalence of severe manifestations of AWS, ICU and hospital lengths of stay, and incidence of potentially significant drug interactions.Results: A total of 172 patients were included (T: n = 81, NT: n = 91). Baseline characteristics were similar between groups, including history of severe AWS and cumulative benzodiazepine dose pre-PHB. There was no difference in the primary outcome between groups (T: 70.4% vs NT: 59.3%, P = 0.152). The median number of adjunctive agents per patient, severe manifestations, and ICU and hospital length of stay did not differ between groups. Twenty-five patients (14.5%) had potentially significant drug interactions.Conclusion and Relevance: The use of a PHB loading dose without a taper may be comparable to a taper strategy on clinical outcomes. Prospective studies are needed to further delineate the optimal dose of PHB for AWS.
引用
收藏
页数:9
相关论文
共 50 条
  • [1] EVALUATION OF ADJUNCTIVE PHENOBARBITAL FOR THE MANAGEMENT OF ALCOHOL WITHDRAWAL SYNDROME
    Hite, Mindee
    Silinskie, Kevin
    [J]. CRITICAL CARE MEDICINE, 2019, 47
  • [2] Gabapentin withdrawal syndrome in the presence of a taper
    Tran, KT
    Hranicky, D
    Lark, T
    Jacob, NJ
    [J]. BIPOLAR DISORDERS, 2005, 7 (03) : 302 - 304
  • [3] Retrospective analysis of a gabapentin high dose taper compared to lorazepam in acute inpatient alcohol withdrawal
    Morrison, Matthew
    Udeh, Elizabeth
    Burak, Michelle
    [J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2019, 45 (04): : 385 - 391
  • [4] Phenobarbital for alcohol withdrawal syndrome
    Rodgers, JE
    Crouch, MA
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (02) : 175 - 178
  • [5] WITHDRAWAL SYNDROME FOLLOWING BETA-BLOCKER TAPER
    不详
    [J]. AMERICAN JOURNAL OF NURSING, 1988, 88 (10) : 1375 - 1376
  • [6] PHENOBARBITAL COMPARED TO BENZODIAZEPINES FOR ALCOHOL WITHDRAWAL SYNDROME IN THE INTENSIVE CARE UNIT
    Boyd, Carly
    Moon, Julie
    Sikand, Harminder
    [J]. CRITICAL CARE MEDICINE, 2022, 50 (01) : 465 - 465
  • [7] Current evidence and clinical utility of phenobarbital for alcohol withdrawal syndrome
    Nishimura, Yoshito
    Choi, Horyun
    Colgan, Bridget
    Kistler, Harrison
    Mercado, Francisco
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2023, 112 : 52 - 61
  • [8] EVALUATION OF PHENOBARBITAL DOSING IN HOSPITALIZED PATIENTS WITH ALCOHOL WITHDRAWAL SYNDROME
    Stallworth, Sara
    Stilley, Kelsey
    Viriyakitja, Wassamon
    Powers, Shelby
    Parish, Alice
    Erkanli, Alaattin
    Komisar, Jonathan
    [J]. CRITICAL CARE MEDICINE, 2024, 52
  • [9] Clinical management of the alcohol withdrawal syndrome
    Day, Ed
    Daly, Chris
    [J]. ADDICTION, 2022, 117 (03) : 804 - 814
  • [10] COMPARISON OF TWO PHENOBARBITAL DOSING STRATEGIES FOR THE MANAGEMENT OF ALCOHOL WITHDRAWAL SYNDROME
    Thaller, Matthew
    Wong, Adrian
    Eche, Ifeoma
    Yankama, Tuyen
    Elsamadisi, Pansy
    [J]. CRITICAL CARE MEDICINE, 2023, 51 (01) : 377 - 377